Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

NHS Accelerated Access Collaborative launched NHS Innovation Service in England

In July 2022, NHS Accelerated Access Collaborative launched a new NHS Innovation Service to support the spread of promising and impactful innovations. It is an online service for health innovators (individuals and companies) providing tailored and coordinated support or advice for "adoption-ready" products. The service will help innovators to understand the regulations and standards they need to meet, the evidence they should demonstrate, and the NHS procurement and reimbursement processes.

Innovators using the service may receive help from all 15 Academic Health Science Networks (AHSNs) and nine national organizations, including NICE, Medicines and Healthcare Products Regulatory Agency (MHRA), National Institute for Health Research (NIHR), Scottish Health Technologies Group (SHTG), Health Technology Wales (HTW), and NHS Supply Chain.

AHSNs held a webinar and issued a new booklet introducing the NHS Innovation Service and explaining the various levels of support an AHSN can offer.

See the full details here.

See the AHSNs booklet and webinar record here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).